Strategic Advisory
Total Trials
5
As Lead Sponsor
1
As Collaborator
4
Total Enrollment
7,624
NCT03332992
Comparative Tests of Flu Vaccination Phone Messages
Phase: N/A
Role: Collaborator
Start: Nov 11, 2017
Completion: Apr 30, 2018
NCT05564793
Improving CRT Outcome With Non-Invasive Cardiac Mapping
Role: Lead Sponsor
Start: Dec 20, 2023
Completion: Dec 31, 2027
NCT06467201
SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of KSHN001126 in Healthy Post-Menopausal Females
Phase: Phase 1
Start: Jun 30, 2024
Completion: Mar 31, 2025
NCT06806995
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.
Start: Jan 21, 2025
Completion: Feb 17, 2025
NCT06995482
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers
Start: May 31, 2025
Completion: Apr 30, 2026
Loading map...